Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Rheumatology 3, 14–15 (1 January 2007) | doi:10.1038/ncprheum0376
Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis
&
Abstract
Setoguchi S et al. (2006) Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 54: 2757–2764 Synopsis Background Information from previous studies and the FDA's postmarketing system for reporting spontaneous adverse events have raised safety concerns about a possible association between treatment with tumor necrosis factor (TNF) antagonists and malignancy.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
